An adMare Tx Accelerator company, NorthMiRs has won the first prize of $250K at ECHO PITCH 2024. It was one of the four selected startups in the cardiovascular sector to compete for this generous award and they created a great impact on the judges of the competition.
The Entrepreneurship for Cardiovascular Health Opportunities (ECHO) PITCH 2024 is a very reputable platform for those who want to showcase their innovation and has a huge popularity among its audience of scientists, investors, clinicians, and entrepreneurs.
NorthMiRs is working on novel RNA-based therapeutics that have the capability to disrupt the healthcare and medical field and will help in the treatment of sepsis and related conditions. NM-001 is the primary product of the company that is used in the treatment of sepsis-induced cardiac dysfunction, which is a condition in which the heart’s functioning is disturbed due to an infection in the body.
Samantha McWhirter is the Co-founder and CEO of NorthMiRs and she said that the funding will go towards the essential testing of their primary product.
